Carl Eibl

CARL EIBL joined Maxwell Technologies, Inc., as President and Chief
Executive Officer in December 1999, after serving as an independent
member of the company’s Board of Directors since 1998. From February
1999 until he joined Maxwell, he was President and a Director of
Stratagene Corporation, a privately held developer and supplier of
laboratory instruments and biological tools to the life science
industry. Previously, he was President and Chief Executive of Mycogen
Corporation, a publicly held agricultural biotechnology company that
attained a market capitalization of $1.1 billion and was acquired by Dow
Chemical in 1998.